Stress Incontinence Surgery
On this page
Direct answer
Surgery for genuine stress urinary incontinence has converged on the mid-urethral sling: a narrow polypropylene tape placed tension-free at the mid-urethra, retropubically (TVT) or through the obturator foramen (TOT), curing or substantially improving symptoms in the great majority of appropriately selected women. The tape works as a dynamic backboard — the urethra compresses against it during effort — rather than by mechanically lifting the bladder neck. Alternatives persist for specific situations: Burch colposuspension, autologous fascial pubovaginal slings for intrinsic sphincter deficiency, and periurethral bulking agents for unfit or high-risk patients. Conservative therapy always comes first, and every operation shares the same postoperative ritual — confirming the woman can void.
What you must remember
- Conservative first: pelvic floor muscle training for at least three months, weight loss and cough management precede surgery; urodynamics are individualised in uncomplicated cases but expected where the diagnosis is complex.
- The tape: macroporous polypropylene, tension-free at the mid-urethra; retropubic route (cough test under local anaesthesia adjusts tension) versus transobturator route (less bladder risk, more groin pain).
- Cure figures: dry-rate or substantial improvement in roughly 85–90% short term, sustained around 70–80% at five years or more — numbers to quote, not to round up to 100.
- Complications: bladder perforation with retropubic passage (a few percent — cystoscopy mandatory), voiding dysfunction and retention, de novo urgency, mesh exposure or erosion around 2–3%, groin and thigh pain with obturator tapes, and rare vascular or bowel injury.
- Mesh governance: safety debates paused mid-urethral slings in some countries (Scotland; NICE restrictions in England, later partially relaxed), with Indian practice governed by FOGSI guidance and institutional consent standards — selective, informed use is the defensible position.
- Alternatives: Burch colposuspension (equivalent long-term, more morbidity), autologous rectus fascia sling (gold standard for intrinsic sphincter deficiency and mesh refusal), bulking agents (modest, repeating benefit for unfit women), and colposuspension-type anterior repairs are no longer stand-alone cures.
- Postoperative care: trial of void with residual checks, restriction of heavy lifting and straining for about 6 weeks, and counselling that recurrence after menopause or new prolapse may need review.
- Special situations: mixed incontinence (surgery treats the stress component; urgency may persist), prior failed sling (urodynamics and imaging before revision), and recurrence is managed with repeat sling or bulking depending on findings.
From cough test to trial of void
A 49-year-old with pure stress incontinence, urethral hypermobility and failed pelvic floor training chooses a retropubic mid-urethral sling under local anaesthesia with sedation. Mid-procedure the surgeon runs a cough test — urine leak beside the sheath says the tape is not too tight, and it is adjusted to sit lightly against the urethra before the sheath is withdrawn. Cystoscopy follows and finds no perforation; the residuals after three hours are comfortable, and she voids with a residual of 40 mL by evening. Contrast two variants that test the same operation: her neighbour with transobturator tape wakes with right groin pain — the commonest obturator-route complaint, self-limiting but named before consent — and a 71-year-old with a fixed urethra after radiotherapy leaves the sling clinic with a bulking-agent plan instead, because a standard tape in a scarred, sphincter-deficient urethra obstructs without curing. The through-line is that technique, route and patient geometry decide outcomes more than any single product, and the counselling states the 85–90% figure alongside its complications in the same breath.
Where students slip
The first slip is mechanism: candidates describe the tape as a hammock that "supports" and stop there; the marks come from the mid-urethral position and effort-compression concept, which is also why overtensioning causes obstruction and de novo urgency. The second is the cystoscopy habit — forgetting that retropubic tape passage carries occult bladder perforation in a few percent turns a routine safety step into a missed-erosion story later. Students also mishandle the mesh question: quoting the controversy without the selective-use position loses the calibrated answer. Finally, the voiding aftercare is examined as often as the surgery: trial of void, residual measurement and six weeks without heavy lifting separate a complete answer from an operative sketch. Knowing bulking agents suit intrinsic sphincter deficiency while slings suit hypermobility closes the selection logic the exam keeps testing.
Frequently asked questions
How does a mid-urethral sling work?
A tension-free polypropylene tape at the mid-urethra provides a backboard against which the urethra compresses during raised abdominal pressure, without elevating the bladder neck.
What cure rate should be quoted to patients?
Around 85–90% cure or substantial improvement short term, with roughly 70–80% maintained beyond five years.
Why is cystoscopy performed after retropubic sling placement?
To exclude occult bladder perforation from the trocar passage — a few percent of cases — before the patient leaves theatre.
Which operation is preferred for intrinsic sphincter deficiency?
An autologous rectus fascia pubovaginal sling, or periurethral bulking agents in women unfit for larger surgery.
What postoperative monitoring is routine?
Trial of void with post-void residual checks, avoidance of heavy lifting for about six weeks, and review for de novo urgency or voiding difficulty.